Picture Kentro Design Corporate and Web Design Berlin 600x60px
Document › Details

Merck KGaA. (5/9/14). "Press Release: Wolfgang Büchele Elected Supervisory Board Chairman of Merck". Frankfurt.

Organisations Organisation Merck KGaA
  Group Merck (DE) (Group)
  Organisation 2 Linde AG
  Group Linde (Group)
Products Product pharmaceutical
  Product 2 CHEMICALS
Person Person Büchele, Wolfgang (Linde 201405 designated CEO + Board Chairman of Merck KGaA)

> Annual General Meeting approves dividend increase and share split

> Executive Board actions approved by significant majority

The newly appointed Supervisory Board of Merck today elected at its inaugural meeting Wolfgang Büchele as the Chairman of this corporate governance body. Before that, the Annual General Meeting had elected the eight shareholder representatives. The eight employee representative members of the Supervisory Board had already been elected in April. The term of office of the previous Supervisory Board members expired upon conclusion of the Annual General Meeting. The new term of office runs until the conclusion of the Annual General Meeting that will resolve on the approval of the actions of the Executive Board for fiscal 2018.

At today's Annual General Meeting, the shareholders also approved the increase of € 0.20 in the dividend to € 1.90, which corresponds to a total dividend payment of approximately € 413 million and a payout ratio of around 31%. Shareholders also voted in favor of the proposed 2:1 share split.

The Annual General Meeting approved the actions of the Executive Board and the Supervisory Board for fiscal 2013 by a significant majority and approved all the resolutions except for one. Not approved was resolution 9 relating to the possibility of excluding subscription rights in the case of capital increases through contributions in kind, which was voted on as an amendment to the existing authorized capital.

The reason for not reaching the necessary 75 percent majority are stricter guidelines for foreign investors in comparison to German investors regarding the acceptance of capital measures at annual general meetings.

More than 800 shareholders took part in the Annual General Meeting. When the resolutions were voted on, 41,262,543 shares were represented, corresponding to 63.85% of the approximately 64.6 million shares issued.

All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website Please go to to register online, change your selection or discontinue this service.

Merck is a leading company for innovative and top-quality high-tech products in the pharmaceutical and chemical sectors. With its four divisions Merck Serono, Consumer Health, Performance Materials and Merck Millipore, Merck generated total revenues of € 11.1 billion in 2013. Around 38,000 Merck employees work in 66 countries to improve the quality of life for patients, to further the success of customers and to help meet global challenges. Merck is the world's oldest pharmaceutical and chemical company - since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70 percent interest, the founding family remains the majority owner of the company to this day. Merck, Darmstadt, Germany is holding the global rights to the Merck name and brand. The only exceptions are Canada and the United States, where the company is known as EMD.

Record changed: 2017-04-02


Picture [LSUS] – The Business Web Portal 600x60px

More documents for Merck (DE) (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top